HL Pharma shares pharmaceutical news, industry updates and practical guidance for sponsors, healthcare providers and supply partners across Australia.
Building on its range of licensed products, HL Pharma is excited announce it now has the exclusive Australian distribution rights for the Carnation® Footcare product range and Carnation® Corn Caps. Product distribution will be available from September 2023.
read moreThe Therapeutic Goods Administration (TGA) has issued 5 infringement notices totalling $13,320 to 3 health practitioners for the alleged unlawful importation of unregistered prescription-only medicines.
read moreHL Pharma is excited to announce Dr Paula Martin has joined the team, partnering on the WomanCare Global obstetric and gynaecological product range.
read moreA US physician, Dr Joan Fleischman believes training doctors in this easy method for miscarriage extraction and abortion, might be the best way to address the health care shortfall in this area of woman’s reproductive health, by making this easy procedure more accessible.
read moreFrom 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions through the Special Access Scheme.
read moreHL Pharma is the distributor of the ARTG registered product Hope Pharmaceuticals Sodium Thiosulfate Pentahydrate 12.5 g/50 mL solution for Injection Vial (theProduct), sponsored by Hope Pharmaceuticals Pty Ltd (AUST R 276733)
read more
